These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19336475)

  • 1. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk.
    Drenos F; Talmud PJ; Casas JP; Smeeth L; Palmen J; Humphries SE; Hingorani AD
    Hum Mol Genet; 2009 Jun; 18(12):2305-16. PubMed ID: 19336475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
    PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration.
    Angelakopoulou A; Shah T; Sofat R; Shah S; Berry DJ; Cooper J; Palmen J; Tzoulaki I; Wong A; Jefferis BJ; Maniatis N; Drenos F; Gigante B; Hardy R; Laxton RC; Leander K; Motterle A; Simpson IA; Smeeth L; Thomson A; Verzilli C; Kuh D; Ireland H; Deanfield J; Caulfield M; Wallace C; Samani N; Munroe PB; Lathrop M; Fowkes FG; Marmot M; Whincup PH; Whittaker JC; de Faire U; Kivimaki M; Kumari M; Hypponen E; Power C; Humphries SE; Talmud PJ; Price J; Morris RW; Ye S; Casas JP; Hingorani AD
    Eur Heart J; 2012 Feb; 33(3):393-407. PubMed ID: 21804106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
    Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
    Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE/C1/C4/C2 gene cluster genotypes, haplotypes and lipid levels in prospective coronary heart disease risk among UK healthy men.
    Ken-Dror G; Talmud PJ; Humphries SE; Drenos F
    Mol Med; 2010; 16(9-10):389-99. PubMed ID: 20498921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men.
    Ken-Dror G; Drenos F; Humphries SE; Talmud PJ; Hingorani AD; Kivimäki M; Kumari M; Bauer KA; Morrissey JH; Ireland HA
    J Thromb Haemost; 2010 Nov; 8(11):2394-403. PubMed ID: 20735728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of statistical and functional methodologies for the investigation of genetic determinants of coronary heart disease biomarkers: lipoprotein lipase genotype and plasma triglycerides as an exemplar.
    Smith AJ; Palmen J; Putt W; Talmud PJ; Humphries SE; Drenos F
    Hum Mol Genet; 2010 Oct; 19(20):3936-47. PubMed ID: 20650961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian randomization of blood lipids for coronary heart disease.
    Holmes MV; Asselbergs FW; Palmer TM; Drenos F; Lanktree MB; Nelson CP; Dale CE; Padmanabhan S; Finan C; Swerdlow DI; Tragante V; van Iperen EP; Sivapalaratnam S; Shah S; Elbers CC; Shah T; Engmann J; Giambartolomei C; White J; Zabaneh D; Sofat R; McLachlan S; ; Doevendans PA; Balmforth AJ; Hall AS; North KE; Almoguera B; Hoogeveen RC; Cushman M; Fornage M; Patel SR; Redline S; Siscovick DS; Tsai MY; Karczewski KJ; Hofker MH; Verschuren WM; Bots ML; van der Schouw YT; Melander O; Dominiczak AF; Morris R; Ben-Shlomo Y; Price J; Kumari M; Baumert J; Peters A; Thorand B; Koenig W; Gaunt TR; Humphries SE; Clarke R; Watkins H; Farrall M; Wilson JG; Rich SS; de Bakker PI; Lange LA; Davey Smith G; Reiner AP; Talmud PJ; Kivimäki M; Lawlor DA; Dudbridge F; Samani NJ; Keating BJ; Hingorani AD; Casas JP
    Eur Heart J; 2015 Mar; 36(9):539-50. PubMed ID: 24474739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease.
    Ganna A; Salihovic S; Sundström J; Broeckling CD; Hedman AK; Magnusson PK; Pedersen NL; Larsson A; Siegbahn A; Zilmer M; Prenni J; Arnlöv J; Lind L; Fall T; Ingelsson E
    PLoS Genet; 2014 Dec; 10(12):e1004801. PubMed ID: 25502724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
    Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].
    Mierzecki A; Bukowska H; Honczarenko K; Jastrzebska M; Millo B; Torbus-Lisiecka B
    Pol Arch Med Wewn; 2005 Feb; 113(2):119-29. PubMed ID: 16209232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
    Ridker PM; Stampfer MJ; Rifai N
    JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
    Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
    Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the role of interleukin 6 receptor haplotypes in the regulation of circulating levels of inflammatory biomarkers and risk of coronary heart disease.
    Gigante B; Strawbridge RJ; Velasquez IM; Golabkesh Z; Silveira A; Goel A; Baldassarre D; Veglia F; Tremoli E; Clarke R; Watkins H; Hamsten A; Humphries SE; de Faire U
    PLoS One; 2015; 10(3):e0119980. PubMed ID: 25781951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.